Youssef, Gilbert
Wen, Patrick Y.
Article History
Accepted: 11 December 2023
First Online: 3 January 2024
Declarations
:
: Gilbert Youssef declares no potential conflicts of interest. Patrick Y. Wen has received nonfinancial support and serves on advisory board and consultant for Astra Zeneca, Black Diamond, Chimetrix, Merck, Novartis, Servier, VBI Vaccines, Anheart, Celularity, Day One Bio, Genenta, Glaxo Smith Kline, Kintara, Mundipharma, Novartis, Novocure, Prelude Therapeutics, Sagimet, Sapience, Symbio, and Tango, and Telix. Dr. Wen has also received nonfinancial support from Bristol Meyers Squibb, Eli Lily, Erasca, Global Coalition for Adaptive Research, Kazia, Medicinova, and Quadriga.
: This article does not contain any studies with human or animal subjects performed by any of the authors.